Currently, in Europe, the first of these two drugs, lecanemab, has not received approval from the regulatory agency EMA, ...

CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's ...

President elect Trump says RFK Jr, can go "wild on health." Some pediatricians worry this could mean a roll back of childhood vaccinations which would accelerate the reemergence of childhood diseases.

In an age where oral health is paramount, GumAktiv emerges as a revolutionary product designed to support your dental ...

Received a "Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) to evaluate amezalpat in combination ...

"Generic drugs are used around the world. There are no doubts about their safety and efficacy as they have undergone ...

A new proven protocol in which doxycycline is used to prevent sexually transmitted infections, called doxyPEP, has been an ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The BRIGHT trial will evaluate HG202's safety, efficacy, and potential to improve visual acuity and reduce anti-VEGF ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...